Glucose-6-phosphate dehydrogenase deficiency primary prevention: Difference between revisions
Created page with "{{Glucose-6-phosphate dehydrogenase deficiency}} {{CMG}}; '''Associate Editor(s)-In-Chief:''' Priyamvada Singh, M.D. [mailto:psingh@perfuse.org] ==Overvi..." |
Shyam Patel (talk | contribs) No edit summary |
||
| (9 intermediate revisions by 3 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | |||
{{Glucose-6-phosphate dehydrogenase deficiency}} | {{Glucose-6-phosphate dehydrogenase deficiency}} | ||
{{CMG}}; | {{CMG}} {{shyam}}; {{AE}} {{MA}} | ||
==Overview== | ==Overview== | ||
deficiency | Effective measures for the primary prevention of G6PD deficency include avoiding triggers. | ||
==Primary Prevention== | |||
Effective measures for the primary prevention of G6PD deficiency include:<ref name="pmid27040960">{{cite journal |vauthors=Luzzatto L, Nannelli C, Notaro R |title=Glucose-6-Phosphate Dehydrogenase Deficiency |journal=Hematol. Oncol. Clin. North Am. |volume=30 |issue=2 |pages=373–93 |date=April 2016 |pmid=27040960 |doi=10.1016/j.hoc.2015.11.006 |url=}}</ref> | |||
*Avoiding triggers (some foods and drugs): | |||
**Fava beans | |||
**Sulfa drugs | |||
**Primiquine | |||
**Nitrodurantoin | |||
**Rasburicase | |||
*Administration of vaccines: | |||
**Hepatitis A and B vaccines are recommended for G6PD defeceincy patients to prevent attacks due to infection.<ref name="pmid18159462">{{cite journal |vauthors=Monga A, Makkar RP, Arora A, Mukhopadhyay S, Gupta AK |title=Case report: Acute hepatitis E infection with coexistent glucose-6-phosphate dehydrogenase deficiency |journal=Can J Infect Dis |volume=14 |issue=4 |pages=230–1 |date=July 2003 |pmid=18159462 |pmc=2094938 |doi= |url=}}</ref> | |||
==References== | ==References== | ||
{{ | {{Reflist|2}} | ||
{{WH}} | |||
{{WS}} | |||
Latest revision as of 23:41, 19 December 2018
|
Glucose-6-phosphate dehydrogenase deficiency Microchapters |
|
Differentiating Glucose-6-phosphate dehydrogenase deficiency from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Glucose-6-phosphate dehydrogenase deficiency primary prevention On the Web |
|
American Roentgen Ray Society Images of Glucose-6-phosphate dehydrogenase deficiency primary prevention |
|
FDA on Glucose-6-phosphate dehydrogenase deficiency primary prevention |
|
CDC on Glucose-6-phosphate dehydrogenase deficiency primary prevention |
|
Glucose-6-phosphate dehydrogenase deficiency primary prevention in the news |
|
Blogs on Glucose-6-phosphate dehydrogenase deficiency primary prevention |
|
Directions to Hospitals Treating Glucose-6-phosphate dehydrogenase deficiency |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Shyam Patel [2]; Associate Editor(s)-in-Chief: Mahda Alihashemi M.D. [3]
Overview
Effective measures for the primary prevention of G6PD deficency include avoiding triggers.
Primary Prevention
Effective measures for the primary prevention of G6PD deficiency include:[1]
- Avoiding triggers (some foods and drugs):
- Fava beans
- Sulfa drugs
- Primiquine
- Nitrodurantoin
- Rasburicase
- Administration of vaccines:
- Hepatitis A and B vaccines are recommended for G6PD defeceincy patients to prevent attacks due to infection.[2]
References
- ↑ Luzzatto L, Nannelli C, Notaro R (April 2016). "Glucose-6-Phosphate Dehydrogenase Deficiency". Hematol. Oncol. Clin. North Am. 30 (2): 373–93. doi:10.1016/j.hoc.2015.11.006. PMID 27040960.
- ↑ Monga A, Makkar RP, Arora A, Mukhopadhyay S, Gupta AK (July 2003). "Case report: Acute hepatitis E infection with coexistent glucose-6-phosphate dehydrogenase deficiency". Can J Infect Dis. 14 (4): 230–1. PMC 2094938. PMID 18159462.